CeriBell, Inc. (CBLL)
NASDAQ: CBLL · Real-Time Price · USD
17.83
-0.06 (-0.34%)
Mar 6, 2026, 4:00 PM EST - Market closed

Company Description

CeriBell, Inc. operates as a medical technology company in the United States.

It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting.

The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm.

In addition, it operates an EEG portal, which enables real-time remote access to a patient’s EEG data.

The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015.

CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

CeriBell, Inc.
CeriBell logo
Country United States
Founded 2014
IPO Date Oct 11, 2024
Industry Medical Devices
Sector Healthcare
Employees 327
CEO Xingjuan Chao

Contact Details

Address:
360 North Pastoria Avenue
Sunnyvale, California 94085
United States
Phone 800 436 0826
Website ceribell.com

Stock Details

Ticker Symbol CBLL
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $17.00
CIK Code 0001861107
CUSIP Number 15678C102
ISIN Number US15678C1027
Employer ID 47-1785452
SIC Code 3845

Key Executives

Name Position
Dr. Xingjuan Chao Ph.D. Co-Founder, President, Chief Executive Officer and Director
Dr. Josef Parvizi M.D., Ph.D. Co-Founder, Chief Medical Advisor and Director
Scott Blumberg Chief Financial Officer
Dr. Raymond Woo Ph.D. Chief Technology Officer
Dan Rogy Senior Vice President of Operations
Louisa Daniels J.D., M.B.A. General Counsel
Brian P. Price Senior Vice President of Marketing
Kim McKeon Vice President of People and Culture
Baharan Kamousi Ph.D. Senior Vice President of Data Science
Sean Manni Chief Revenue Officer

Latest SEC Filings

Date Type Title
Mar 3, 2026 144 Filing
Mar 3, 2026 144 Filing
Mar 3, 2026 144 Filing
Mar 2, 2026 144 Filing
Feb 24, 2026 S-8 Securities to be offered to employees in employee benefit plans
Feb 24, 2026 10-K Annual Report
Feb 24, 2026 8-K Current Report
Feb 24, 2026 144 Filing
Feb 23, 2026 144 Filing
Feb 23, 2026 144 Filing